Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation on May 25, 2016. The filing addresses corporate governance changes, specifically the departure of a director and the appointment of compensatory arrangements for an officer of its subsidiary, Lifecore Biomedical, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Director Departure: Nicholas Tompkins advised the Board on May 25, 2016, that he would retire from the Board of Directors effective at the 2016 annual meeting of stockholders.
- Executive Compensation Grant: The Board approved a grant to Larry Hiebert, President of Lifecore Biomedical, Inc. (a subsidiary), consisting of:
- 15,000 stock options vesting monthly over three years.
- 5,000 restricted stock units vesting on the third anniversary of the grant.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the date of the 2016 annual meeting of stockholders to confirm the effective date of Nicholas Tompkins' retirement.
- Review the specific terms of the stock option and restricted stock unit agreements granted to Larry Hiebert for performance conditions or acceleration clauses.
- Confirm the current composition of the Board of Directors following the announced departure.